Avalyn Pharma Inc.
Research Avalyn Pharma Inc. (AVLN) on Bullrun: market cap USD 1.30B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerAVLN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 1.30B
- Financial periodQ1 2026
- Net income-USD 26.87M
- Free cash flow-USD 30.21M
Valuation Snapshot
latest market cap is USD 1.30B.
About Avalyn Pharma Inc.
Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis.
Frequently asked questions
What is Avalyn Pharma Inc.'s market cap?
Avalyn Pharma Inc.'s market capitalization is USD 1.30B.
What does Avalyn Pharma Inc. do?
Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs.